Skip to main content
. 2016 Aug 29;2016:9742034. doi: 10.1155/2016/9742034

Figure 1.

Figure 1

Characterization of UC-MSCs. (a) Morphological changes and characterization of UC-MSCs. (b) The viability of UC-MSCs after plating from day 1 to day 7 measured by MTT assay. (c) The expression of cell surface markers measured by flow cytometry. UC-MSCs positively expressed CD13, CD73, CD90, and CD105 but negatively expressed CD34 and CD45. represents p < 0.05.